Healthcare M&A Oncology

Illumina Set to Acquire Grail for $8B

Released on September 21, 2020

The rumors are indeed true – Illumina is attempting to acquire early cancer detection specialist Grail for about $8 billion. Both […]

Read more
Imaging M&A Oncology

Bruker acquires Canopy Biosciences

Released on September 11, 2020

Bruker Corp. (NSDQ:BRKR) announced today that it acquired biomarker imaging technology developer Canopy Biosciences. Billerica, Mass.-based Bruker said in a news release that […]

Read more
AI AR/VR Oncology

DoD taps Google Cloud for digital pathology pilot

Released on September 7, 2020

The Department of Defense is launching a digital pathology pilot program that would use AI combined with augmented reality microscopes to […]

Read more
MedTech Oncology Women's Health

FDA: Thousands of new breast-implant-related illnesses reported

Released on August 24, 2020

The FDA today reported that it has received nearly 2,500 new reports globally of “breast implant illness” or BII. Reports of […]

Read more
Diagnostics FDA Cleared Oncology

Guardant companion diagnostic gets FDA nod as 1st liquid biopsy with NGS

Released on August 10, 2020

Dive Brief: FDA Friday approved Guardant Health’s liquid biopsy diagnostic that uses next-generation sequencing (NGS) to identify patients with mutations of […]

Read more
MedTech Oncology

Guardant growth slows in Q2 but still tops expectations

Released on August 7, 2020

Dive Brief: Guardant Health’s second quarter sales bump of 23% to roughly $66 million beat analysts’ estimates as both its precision oncology and development […]

Read more
M&A MedTech Oncology

Varian sold to Siemens Healthineers in $16.4B all-cash deal

Released on August 2, 2020

Dive Brief: Siemens Healthineers will buy radiation oncology systems and software maker Varian Medical in an all-cash deal valued at $16.4 […]

Read more
Funding Imaging Oncology

Sirius Medical raises nearly $5m to commercialize non-radioactive tumor localization system

Released on July 16, 2020

Sirius Medical has raised €4.4 million ($4.9 million) as it seeks to commercialize its Sirius Pintuition non-radioactive tumor localization system. News of […]

Read more
MedTech Oncology Radiology

Hologic Releases SuperSonic MACH 40 Breast Ultrasound in U.S.

Released on July 10, 2020

Hologic is launching in the U.S. its first cart-based breast ultrasound system, the SuperSonic MACH 40. The company touts the device […]

Read more
Imaging Oncology

FDA clears Therapixel’s Mammoscreen

Released on July 10, 2020

Therapixel today said it received FDA 510(k) clearance for its MammoScreen artificial intelligence-used software. MammoScreen automatically detects and characterizes suspicious soft […]

Read more
Diagnostics M&A Oncology

Lantheus, Progenics complete merger

Released on June 22, 2020

Lantheus Medical Imaging (NSDQ:LNTH) parent company Lantheus Holdings announced the completion of its merger with Progenics Pharmaceuticals. Progenics, an oncology company developing medicines […]

Read more
CE Mark Imaging Oncology

Sirius Medical wins CE mark for non-radioactive localization system

Released on June 17, 2020

Sirius Medical announced that it received CE Mark approval for its Sirius Pintuition non-radioactive tumor localization system. Eindhoven, the Netherlands-based Sirius said […]

Read more